Invex Therapeutics Ltd banner

Invex Therapeutics Ltd
ASX:IXC

Watchlist Manager
Invex Therapeutics Ltd Logo
Invex Therapeutics Ltd
ASX:IXC
Watchlist
Price: 0.12 AUD Market Closed
Market Cap: AU$9m

Intrinsic Value

The intrinsic value of one IXC stock under the Base Case scenario is 0.05 AUD. Compared to the current market price of 0.12 AUD, Invex Therapeutics Ltd is Overvalued by 59%.

IXC Intrinsic Value
0.05 AUD
Overvaluation 59%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Invex Therapeutics Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about IXC?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is IXC valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Invex Therapeutics Ltd.

Explain Valuation
Compare IXC to

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Invex Therapeutics Ltd

Wall St
Price Targets

Dividends

Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one IXC stock?

The intrinsic value of one IXC stock under the Base Case scenario is 0.05 AUD.

Is IXC stock undervalued or overvalued?

Compared to the current market price of 0.12 AUD, Invex Therapeutics Ltd is Overvalued by 59%.

Back to Top